RACHEL ROY: Open Payments
NPI 1346899465 · DALE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 16 payments from 10 companies in 2025. Trend: 2023 $294 · 2024 $460 · 2025 $293
Food & beverage: $248Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| Lilly USA, LLC | 2 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| PFIZER INC. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $7 |
Products named: UBRELVY, ABILIFY ASIMTUFII, PREVNAR 20, AUSTEDO XR, REXULTI, QULIPTA, MOUNJARO, Auvelity.
Industry payments across IN — which companies pay providers there.
